Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Strnad

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|June 5, 2026
Loss of the mechanistic target of rapamycin complexes 1 (mTORC1) causes a lethal alpha-1 antitrypsin deficiency associated liver diseaseLisa Bewersdorf, Sophie Haber, Ines Volkert, et al.
Mucosal Immunology|August 18, 2018
Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injuryAnnika Gross, Lotta A P Pack, Gabriel M Schacht, et al.
International Journal of Molecular Sciences|February 11, 2023
Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical CoursesJan C Kamp, Naomi N Kappe, Carlos Fernández Moro, et al.
Hepatology International|January 18, 2023
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosisBerivan Gurbuz, Nurdan Guldiken, Philipp Reuken, et al.
BMC Medicine|February 17, 2021
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseasesNurdan Guldiken, Josepmaria Argemi, Berivan Gurbuz, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2024
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver diseaseRohit Loomba, Ginger Clark, Jeff Teckman, et al.
Frontiers in Medicine|January 28, 2022
Liver Fibrosis-From Mechanisms of Injury to Modulation of DiseaseChristian Liedtke, Yulia A Nevzorova, Tom Luedde, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological DiseasesSophia Heinrich, Andreia Margarida Carvalho de Matos, Jordi Colmenero, et al.
Nature|April 16, 2025
Deep Visual Proteomics maps proteotoxicity in a genetic liver diseaseFlorian A Rosenberger, Sophia C Mädler, Katrine Holtz Thorhauge, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Cellular and Molecular Gastroenterology and Hepatology|June 5, 2026
Loss of the mechanistic target of rapamycin complexes 1 (mTORC1) causes a lethal alpha-1 antitrypsin deficiency associated liver diseaseLisa Bewersdorf, Sophie Haber, Ines Volkert, et al.
Mucosal Immunology|August 18, 2018
Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injuryAnnika Gross, Lotta A P Pack, Gabriel M Schacht, et al.
International Journal of Molecular Sciences|February 11, 2023
Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical CoursesJan C Kamp, Naomi N Kappe, Carlos Fernández Moro, et al.
Hepatology International|January 18, 2023
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosisBerivan Gurbuz, Nurdan Guldiken, Philipp Reuken, et al.
BMC Medicine|February 17, 2021
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseasesNurdan Guldiken, Josepmaria Argemi, Berivan Gurbuz, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2024
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver diseaseRohit Loomba, Ginger Clark, Jeff Teckman, et al.
Frontiers in Medicine|January 28, 2022
Liver Fibrosis-From Mechanisms of Injury to Modulation of DiseaseChristian Liedtke, Yulia A Nevzorova, Tom Luedde, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological DiseasesSophia Heinrich, Andreia Margarida Carvalho de Matos, Jordi Colmenero, et al.
Nature|April 16, 2025
Deep Visual Proteomics maps proteotoxicity in a genetic liver diseaseFlorian A Rosenberger, Sophia C Mädler, Katrine Holtz Thorhauge, et al.
Pageof 23